Compare LESL & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LESL | BMRA |
|---|---|---|
| Founded | 1963 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 11.5M |
| IPO Year | 2020 | 1995 |
| Metric | LESL | BMRA |
|---|---|---|
| Price | $0.23 | $2.39 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $2.54 | N/A |
| AVG Volume (30 Days) | ★ 703.3K | 37.3K |
| Earning Date | 05-18-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.81 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,241,915,000.00 | $4,453,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.62 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $1.45 |
| 52 Week High | $12.53 | $3.21 |
| Indicator | LESL | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 22.51 | 53.87 |
| Support Level | N/A | $2.05 |
| Resistance Level | $0.59 | $2.49 |
| Average True Range (ATR) | 0.06 | 0.21 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 4.46 | 40.23 |
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.